Selected research
Market Structure
Global Biomarker Discovery Outsourcing Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Biomarker Discovery Outsourcing Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Biomarker Discovery Outsourcing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biomarker Discovery Outsourcing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biomarker Discovery Outsourcing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Biomarker Discovery Outsourcing Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Biomarker Discovery Outsourcing Services include Laboratory Corporation of America Holdings, GHO Capital, ICON plc, Agilent, Proteome Sciences, Charles River Laboratories., Eurofins Scientific, Celerion and Evotec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Biomarker Discovery Outsourcing Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biomarker Discovery Outsourcing Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biomarker Discovery Outsourcing Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Biomarker Discovery Outsourcing Services market size, projected growth trends, production technologies, key applications, and end-use industries.
Biomarker Discovery Outsourcing Services Segment by Company
Laboratory Corporation of America Holdings
GHO Capital
ICON plc
Agilent
Proteome Sciences
Charles River Laboratories.
Eurofins Scientific
Celerion
Evotec
Parexel International (MA) Corporation
Biomarker Discovery Outsourcing Services Segment by Type
Predictive biomarkers
Safety biomarkers
Prognostic biomarkers
Others
Biomarker Discovery Outsourcing Services Segment by Application
Biotechnology Company
Pharmaceutical Company
Others
Biomarker Discovery Outsourcing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomarker Discovery Outsourcing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomarker Discovery Outsourcing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomarker Discovery Outsourcing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Biomarker Discovery Outsourcing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biomarker Discovery Outsourcing Services industry.
Chapter 3: Detailed analysis of Biomarker Discovery Outsourcing Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biomarker Discovery Outsourcing Servicesrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Predictive biomarkers
- Safety biomarkers
- Prognostic biomarkers
- Others
Applications
- Biotechnology Company
- Pharmaceutical Company
- Others
Companies covered
- Laboratory Corporation of America Holdings
- GHO Capital
- ICON plc
- Agilent
- Proteome Sciences
- Charles River Laboratories.
- Eurofins Scientific
- Celerion
- Evotec
- Parexel International (MA) Corporation
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Biomarker Discovery Outsourcing Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Predictive biomarkers
- 1.2.3 Safety biomarkers
- 1.2.4 Prognostic biomarkers
- 1.2.5 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Biomarker Discovery Outsourcing Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Biotechnology Company
- 1.3.3 Pharmaceutical Company
- 1.3.4 Others
- 1.4 Global Market Growth Prospects
- 1.5 Global Biomarker Discovery Outsourcing Services Growth Trends by Region
- 1.5.1 Global Biomarker Discovery Outsourcing Services Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Biomarker Discovery Outsourcing Services Market Size by Region (2021-2026)
- 1.5.3 Biomarker Discovery Outsourcing Services Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Biomarker Discovery Outsourcing Services Market Dynamics
- 2.1 Biomarker Discovery Outsourcing Services Industry Trends
- 2.2 Biomarker Discovery Outsourcing Services Industry Drivers
- 2.3 Biomarker Discovery Outsourcing Services Industry Opportunities and Challenges
- 2.4 Biomarker Discovery Outsourcing Services Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Biomarker Discovery Outsourcing Services Revenue by Company (2021-2026)
- 3.2 Global Biomarker Discovery Outsourcing Services Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Biomarker Discovery Outsourcing Services Key Company Head office and Area Served
- 3.4 Global Biomarker Discovery Outsourcing Services Company, Product Type & Application
- 3.5 Global Biomarker Discovery Outsourcing Services Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Biomarker Discovery Outsourcing Services Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Biomarker Discovery Outsourcing Services Players Market Share by Revenue in 2025
- 3.6.3 2025 Biomarker Discovery Outsourcing Services Tier 1, Tier 2, and Tier 3
4 Biomarker Discovery Outsourcing Services Market by Type
- 4.1 Global Biomarker Discovery Outsourcing Services Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Biomarker Discovery Outsourcing Services Market Size by Type (2021-2032)
- 4.3 Global Biomarker Discovery Outsourcing Services Market Size Share by Type (2021-2032)
5 Biomarker Discovery Outsourcing Services Market by Application
- 5.1 Global Biomarker Discovery Outsourcing Services Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Biomarker Discovery Outsourcing Services Market Size by Application (2021-2032)
- 5.3 Global Biomarker Discovery Outsourcing Services Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Laboratory Corporation of America Holdings
- 6.1.1 Laboratory Corporation of America Holdings Company Information
- 6.1.2 Laboratory Corporation of America Holdings Business Overview
- 6.1.3 Laboratory Corporation of America Holdings Biomarker Discovery Outsourcing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Laboratory Corporation of America Holdings Biomarker Discovery Outsourcing Services Product Portfolio
- 6.1.5 Laboratory Corporation of America Holdings Recent Developments
- 6.2 GHO Capital
- 6.2.1 GHO Capital Company Information
- 6.2.2 GHO Capital Business Overview
- 6.2.3 GHO Capital Biomarker Discovery Outsourcing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 GHO Capital Biomarker Discovery Outsourcing Services Product Portfolio
- 6.2.5 GHO Capital Recent Developments
- 6.3 ICON plc
- 6.3.1 ICON plc Company Information
- 6.3.2 ICON plc Business Overview
- 6.3.3 ICON plc Biomarker Discovery Outsourcing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 ICON plc Biomarker Discovery Outsourcing Services Product Portfolio
- 6.3.5 ICON plc Recent Developments
- 6.4 Agilent
- 6.4.1 Agilent Company Information
- 6.4.2 Agilent Business Overview
- 6.4.3 Agilent Biomarker Discovery Outsourcing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Agilent Biomarker Discovery Outsourcing Services Product Portfolio
- 6.4.5 Agilent Recent Developments
- 6.5 Proteome Sciences
- 6.5.1 Proteome Sciences Company Information
- 6.5.2 Proteome Sciences Business Overview
- 6.5.3 Proteome Sciences Biomarker Discovery Outsourcing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Proteome Sciences Biomarker Discovery Outsourcing Services Product Portfolio
- 6.5.5 Proteome Sciences Recent Developments
- 6.6 Charles River Laboratories.
- 6.6.1 Charles River Laboratories. Company Information
- 6.6.2 Charles River Laboratories. Business Overview
- 6.6.3 Charles River Laboratories. Biomarker Discovery Outsourcing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Charles River Laboratories. Biomarker Discovery Outsourcing Services Product Portfolio
- 6.6.5 Charles River Laboratories. Recent Developments
- 6.7 Eurofins Scientific
- 6.7.1 Eurofins Scientific Company Information
- 6.7.2 Eurofins Scientific Business Overview
- 6.7.3 Eurofins Scientific Biomarker Discovery Outsourcing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Eurofins Scientific Biomarker Discovery Outsourcing Services Product Portfolio
- 6.7.5 Eurofins Scientific Recent Developments
- 6.8 Celerion
- 6.8.1 Celerion Company Information
- 6.8.2 Celerion Business Overview
- 6.8.3 Celerion Biomarker Discovery Outsourcing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Celerion Biomarker Discovery Outsourcing Services Product Portfolio
- 6.8.5 Celerion Recent Developments
- 6.9 Evotec
- 6.9.1 Evotec Company Information
- 6.9.2 Evotec Business Overview
- 6.9.3 Evotec Biomarker Discovery Outsourcing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Evotec Biomarker Discovery Outsourcing Services Product Portfolio
- 6.9.5 Evotec Recent Developments
- 6.10 Parexel International (MA) Corporation
- 6.10.1 Parexel International (MA) Corporation Company Information
- 6.10.2 Parexel International (MA) Corporation Business Overview
- 6.10.3 Parexel International (MA) Corporation Biomarker Discovery Outsourcing Services Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Parexel International (MA) Corporation Biomarker Discovery Outsourcing Services Product Portfolio
- 6.10.5 Parexel International (MA) Corporation Recent Developments
7 North America
- 7.1 North America Biomarker Discovery Outsourcing Services Market Size (2021-2032)
- 7.2 North America Biomarker Discovery Outsourcing Services Market Size by Type
- 7.2.1 North America Biomarker Discovery Outsourcing Services Market Size by Type (2021-2026)
- 7.2.2 North America Biomarker Discovery Outsourcing Services Market Size by Type (2027-2032)
- 7.2.3 North America Biomarker Discovery Outsourcing Services Market Share by Type (2021-2032)
- 7.3 North America Biomarker Discovery Outsourcing Services Market Size by Application
- 7.3.1 North America Biomarker Discovery Outsourcing Services Market Size by Application (2021-2026)
- 7.3.2 North America Biomarker Discovery Outsourcing Services Market Size by Application (2027-2032)
- 7.3.3 North America Biomarker Discovery Outsourcing Services Market Share by Application (2021-2032)
- 7.4 North America Biomarker Discovery Outsourcing Services Market Size by Country
- 7.4.1 North America Biomarker Discovery Outsourcing Services Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Biomarker Discovery Outsourcing Services Market Size by Country (2021-2026)
- 7.4.3 North America Biomarker Discovery Outsourcing Services Market Size by Country (2027-2032)
- 7.4.4 North America Biomarker Discovery Outsourcing Services Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Biomarker Discovery Outsourcing Services Market Size (2021-2032)
- 8.2 Europe Biomarker Discovery Outsourcing Services Market Size by Type
- 8.2.1 Europe Biomarker Discovery Outsourcing Services Market Size by Type (2021-2026)
- 8.2.2 Europe Biomarker Discovery Outsourcing Services Market Size by Type (2027-2032)
- 8.2.3 Europe Biomarker Discovery Outsourcing Services Market Share by Type (2021-2032)
- 8.3 Europe Biomarker Discovery Outsourcing Services Market Size by Application
- 8.3.1 Europe Biomarker Discovery Outsourcing Services Market Size by Application (2021-2026)
- 8.3.2 Europe Biomarker Discovery Outsourcing Services Market Size by Application (2027-2032)
- 8.3.3 Europe Biomarker Discovery Outsourcing Services Market Share by Application (2021-2032)
- 8.4 Europe Biomarker Discovery Outsourcing Services Market Size by Country
- 8.4.1 Europe Biomarker Discovery Outsourcing Services Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Biomarker Discovery Outsourcing Services Market Size by Country (2021-2026)
- 8.4.3 Europe Biomarker Discovery Outsourcing Services Market Size by Country (2027-2032)
- 8.4.4 Europe Biomarker Discovery Outsourcing Services Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Biomarker Discovery Outsourcing Services Market Size (2021-2032)
- 9.2 China Biomarker Discovery Outsourcing Services Market Size by Type
- 9.2.1 China Biomarker Discovery Outsourcing Services Market Size by Type (2021-2026)
- 9.2.2 China Biomarker Discovery Outsourcing Services Market Size by Type (2027-2032)
- 9.2.3 China Biomarker Discovery Outsourcing Services Market Share by Type (2021-2032)
- 9.3 China Biomarker Discovery Outsourcing Services Market Size by Application
- 9.3.1 China Biomarker Discovery Outsourcing Services Market Size by Application (2021-2026)
- 9.3.2 China Biomarker Discovery Outsourcing Services Market Size by Application (2027-2032)
- 9.3.3 China Biomarker Discovery Outsourcing Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Biomarker Discovery Outsourcing Services Market Size (2021-2032)
- 10.2 Asia Biomarker Discovery Outsourcing Services Market Size by Type
- 10.2.1 Asia Biomarker Discovery Outsourcing Services Market Size by Type (2021-2026)
- 10.2.2 Asia Biomarker Discovery Outsourcing Services Market Size by Type (2027-2032)
- 10.2.3 Asia Biomarker Discovery Outsourcing Services Market Share by Type (2021-2032)
- 10.3 Asia Biomarker Discovery Outsourcing Services Market Size by Application
- 10.3.1 Asia Biomarker Discovery Outsourcing Services Market Size by Application (2021-2026)
- 10.3.2 Asia Biomarker Discovery Outsourcing Services Market Size by Application (2027-2032)
- 10.3.3 Asia Biomarker Discovery Outsourcing Services Market Share by Application (2021-2032)
- 10.4 Asia Biomarker Discovery Outsourcing Services Market Size by Country
- 10.4.1 Asia Biomarker Discovery Outsourcing Services Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Biomarker Discovery Outsourcing Services Market Size by Country (2021-2026)
- 10.4.3 Asia Biomarker Discovery Outsourcing Services Market Size by Country (2027-2032)
- 10.4.4 Asia Biomarker Discovery Outsourcing Services Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Size by Type
- 11.2.1 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Size by Application
- 11.3.1 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Size by Country
- 11.4.1 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Biomarker Discovery Outsourcing Services Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst